Tag: Immatics
Schott Pharma is aiming for a valuation of 4.3 billion in its IPO
Frankfurt The Mainz-based glass packaging manufacturer Schott Pharma expects a valuation of 3.7 to 4.3 billion euros for its initial public offering (IPO) planned for the end of September. As…
Finding capital for biotech companies remains difficult
biotech research German biotech companies currently have many drugs in clinical trials. (Photo: IMAGO / Shotshop) Frankfurt Since the boom during the corona pandemic, German biotech companies have been raising…
The new magic bullet against cancer
Monday 13 June 2022 Log in subscription Newsletter podcast Club e-paper archive Shop jobs Inside my news Home politics Germany Economy International Economic Education company Industry energy Trade + consumer…
German biotech companies: growth in a difficult environment
on the trail of genes Preparing a sample for genetic analysis: German biotech companies are in demand with investors. (Photo: IMAGO/Westend61) Frankfurt At first glance, investments in the German biotech…
Tübingen-based biotech company Immatics agrees billion-euro deal with Bristol-Myers
researcher in the laboratory The two companies want to jointly develop up to six cell therapies based on standardized, genetically modified immune cells. (Photo: imago images/Panthermedia) Frankfurt The Tübingen-based biotech…
Munich-based biotech company plans to go public on the Nasdaq
Radionuclide Cancer Therapy ITM has been producing radioisotopes for pharmaceutical companies from all over the world since the company was founded. (Photo: ITM) Frankfurt According to financial circles, the Munich-based…
The elite and the corona rules – Handelsblatt Morning Briefing
all people are the same – this is not only known to those who walk around with the Basic Law under their arm. During the lockdown it was even heard…
In the fight against cancer
Frankfurt The fight against the coronavirus has been in the headlines for two years, but there has also been immense progress in the fight against cancer. Because in the long…
Corona tests need a test – Handelsblatt Morning Briefing
Again this week, many Germans will spend their time in the Corona test center or at home with test cassettes (“Where is the line?”). Many need proof of identity for…
In the fight against cancer
Frankfurt The fight against the coronavirus has been in the headlines for two years, but there has also been immense progress in the fight against cancer. Because in the long…
Using killer cells to fight cancer: researchers are promoting CAR therapy
Biontech boss Ugur Sahin, Medigene boss Dolores Schendel, patient Emily Whitehead From the point of view of many experts, the novel immunotherapies mark a new era in cancer treatment, Frankfurt…
Using killer cells to fight cancer: researchers are promoting CAR therapy
Biontech boss Ugur Sahin, Medigene boss Dolores Schendel, patient Emily Whitehead From the point of view of many experts, the novel immunotherapies mark a new era in cancer treatment, Frankfurt…
ITM closes 500 million euro deal with Grand Pharma
Radionuclide cancer therapy ITM has been producing radioisotopes for pharmaceutical companies around the world since the company was founded. Photo: ITM Frankfurt The German biotech company ITM has found a…
$ 900 million deal with pharmaceutical company BMS
Immatics laboratory in Tübingen The biotech company, founded in 2000, develops novel therapies against cancer. (Photo: Immatics Biotechnologies GmbH) Frankfurt The Tübingen-based biotech company Immatics signs a development and marketing…
With donor cells against cancer
Frankfurt Gerhard Ehninger moved a lot in his life – as a doctor and as a researcher. The medical professor co-founded the German bone marrow donor database, taught for two…
Tomorrow’s biontech: venture capitalists reveal Germany’s biotech hopes
Frankfurt The success of the Covid-19 vaccine developer Biontech has brought new attention to German biotech companies. However, regardless of the success of Biontech, the industry has again moved more…